First SquawkNewsroom
Oracle and AstraZeneca sign pact to study AI use in clinical trials
Oracle and AstraZeneca announced a pact to examine how AI is used in clinical trials for cancer and other diseases.
DecryptrNot financial advice. Don't invest unless you're prepared to lose all the money you invest. This is a high-risk investment and you should not expect to be protected if something goes wrong.
First SquawkNewsroom
Oracle and AstraZeneca announced a pact to examine how AI is used in clinical trials for cancer and other diseases.
